Open AccessPerformance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
Author(s) -
Nathalie Renard,
Soizic Daniel,
Nadège Cayet,
Matthieu Pecquet,
Frédérique Raymond,
Sylvie Pons,
Julien Lupo,
Carole Tourneur,
Catherine Pretis,
Guillaume Gerez,
Patrick Blasco,
Maxime Combe,
Imen Canova,
Mylène Lesénéchal,
Franck Berthier
Publication year - 2021
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.02292-20
Subject(s) - serology , pandemic , virology , covid-19 , antibody , coronavirus , immunology , immunoglobulin m , medicine , immunoglobulin g , betacoronavirus , epidemiology , outbreak , pathology , disease , infectious disease (medical specialty)
The COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-specific antibodies plays an important role in understanding and controlling the pandemic, notably through epidemiological surveillance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom